Should blood pressure medication be taken in the morning or evening?

Journal of Hypertension

Volumn 33, Issue 2, 2015, Pages 263-265

  Morgan, Trefor O ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; PERINDOPRIL; TELMISARTAN; TRANDOLAPRIL; VALSARTAN;

ANTIHYPERTENSIVE THERAPY; BEDTIME DOSAGE; DOSAGE SCHEDULE COMPARISON; HUMAN; MORNING DOSAGE; NOTE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; BLOOD PRESSURE; DRUG EFFECTS; HYPERTENSION; MALE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; MALE; VALSARTAN;

EID: 84920774329     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000471     Document Type: Note

References (15)

1. Zappe DH, Crikelair N, Kandra A, Palatini P. Time of administration important? Morning versus evening dosing of valsartan. J Hypertens 2015; 33:385-392.
2. Hermida RC, Ayala DE, Fernández JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 2007; 50:715-722.
3. Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension 2009; 54:40-46.
4. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003; 42:283-290.
5. Lacourcière Y1, Krzesinski JM, White WB, Davidai G, Schumacher H. Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit 2004; 9:203-210.
6. Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens 1997; 15:205-221.
7. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993; 328:303-307.
8. Brandenberger G, Follenius M, Goichot B, Saini J, Ehrhart J, Simon C. Twenty-four-hour profiles of plasma renin activity in relation to the sleep awake cycle. J Hypertens 1994; 12:277-283.
9. Kario K1, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of alpha-adrenergic blocker, doxazosin: results from the HALT study. Hypertension 2000; 35:787-789.
10. Smith DHG, Neutel JM, Black HR, Schoenberger JA, Weber MA. Once daily therapy with trandolapril in the treatment of hypertension. J Hum Hypertens 1996; 10:129-134.
11. Morgan TO, Anderson A. Different drug classes have variable effects on blood pressurede pending on the time of day. Am J Hypertens2003;16:46-50.
12. Morgan TO, Brunner HR, Aubert J-F, Wang Q, Griffiths C, Delbridge L. Cardiac hypertrophy depends upon sleep blood pressure: a study in rats. J Hypertens 2000; 18:445-451.
13. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascularmortality: the Ohasama Study. Hypertension 2005;45:240-245.
14. Staessen JA, Thijs L, Fagard R. Predicting cardiovascular risk using conventional versus ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282:539-546.
15. Morgan TO. The importance of sleep blood pressure. Expert Rev Cardiovasc Ther 2010; 8:803-809.